home  about  experts  links
MPT WWW
 

Category: Health Care Policy

   The U.S. health-care system is a global leader in medical science and innovation of medical technologies. But the foundation of the system—the tax exemption for employer insurance, the regulation of state health-insurance markets, and the fragmentation supported by federal payment policies—encourages an expensive system where the volume of services is encouraged over quality of service for patients, leading to widely varying performance among the nation’s physicians and hospitals, along with uneven access to health care and health insurance. Fixing those problems without crippling medical innovation should be our first priority.

   Unfortunately, policymakers often opt for quick and easy coverage expansions through larger government programs—spending more on public programs like Medicare, Medicaid and SCHIP—without solving the underlying problems that plague the system.

   The United States is in need of deep reforms to the health-care sector of its economy that stress a reformed delivery system, better value in care, respect for state-level reform efforts, more efficient insurance markets, and better tools for tracking and improving patient outcomes. Through market based public policies and smarter investments in safety-net programs, the US can offer all Americans access to high quality health care in a fiscally responsible manner.

[Spotlight] [Commentary] [Research] [Events] [News]


Spotlight


Commentary


Research


News

MPT on Twitter
MPT on Facebook

Conflict of Interest Regulation

Consumer Driven Health Care

Drug & Medical Device Innovation

Drug & Medical Device Litigation

FDA Regulation

Global Health

Health Care Policy

Intellectual Property
Rights & Innovation

Medicare and Medicaid

Personalized Medicine

Value of Medicine


NEW SECOND OPINION!
Experts Discuss Health Reform Legislation in Our "Second Opinion" Expert Forum!

Expert Panel:
  • Diana Furchtgott-Roth
  • David Gratzer
  • Douglas Holtz-Eakin
  • Tom Miller
  • Michael Tanner
  • Grace-Marie Turner

Click here to read their second opinions.

Project FDA.
  
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org